 | Up a level |
Ahmadzadehfar, Hojjat; Seifert, Robert; Afshar Oromieh, Ali; Kratochwil, Clemens; Rahbar, Kambiz (2024). Prostate Cancer Theranostics With 177Lu-PSMA. Seminars in nuclear medicine, 54(4), pp. 581-590. Elsevier 10.1053/j.semnuclmed.2024.02.007
Afshar-Oromieh, Ali; Eiber, Matthias; Fendler, Wolfgang; Schmidt, Matthias; Rahbar, Kambiz; Ahmadzadehfar, Hojjat; Umutlu, Lale; Hadaschik, Boris; Hakenberg, Oliver W; Fornara, Paolo; Kurth, Jens; Neels, O; Wester, Hans-Jürgen; Schwaiger, Markus; Kopka, Klaus; Haberkorn, Uwe; Herrmann, Ken; Krause, Bernd J (2023). [Procedure Guideline for Prostate Cancer Imaging with PSMA-ligand PET/CT]. Nuklearmedizin, 62(1), pp. 5-19. Thieme 10.1055/a-1984-8167
Ahmadzadehfar, Hojjat; Essler, Markus; Rahbar, Kambiz; Afshar Oromieh, Ali (2018). Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning. PET clinics, 13(4), pp. 491-503. Elsevier 10.1016/j.cpet.2018.05.005
Rahbar, Kambiz; Afshar Oromieh, Ali; Jadvar, Hossein; Ahmadzadehfar, Hojjat (2018). PSMA Theranostics: Current Status and Future Directions. Molecular imaging, 17, p. 1536012118776068. SAGE Publications 10.1177/1536012118776068
Ezziddin, Samer; Sabet, Amir; Heinemann, Florian; Yong-Hing, Charlotte J; Ahmadzadehfar, Hojjat; Guhlke, Stefan; Höller, Tobias; Willinek, Winfried; Boy, Christian; Biersack, Hans-Jürgen (2011). Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotate. Journal of nuclear medicine, 52(8), pp. 1197-203. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.111.090373
